The team will use the new research grant to further develop the Stockholm3 prostate cancer test and to design follow-on diagnostics to help treat patients with the disease.
Research centers in six countries will work on metabolome-related global health challenges including autism, cancer, diabetes, dementia, and obesity.
MDNA said the arrangement will help it to quickly build a user base and collect post-market data to demonstrate the test's clinical utility.
The company said in a filing with the US Securities and Exchange Commission that it is not in compliance with the exchange's minimum shareholders' equity requirement.
Exome and transcriptome sequences uncovered features that characterized testicular germ cell tumors by whether they did or did not respond to treatment.
According to Cedars Sinai Medical Center's Jennifer Van Eyk, mass spec-based proteomics' clinical potential is on the cusp of being realized.
Using enhancements to RT-PCR, the firm is able to detect all protein-coding genes in a single-tube multiplex reaction, reducing costs for large-scale projects.
Tempus will sequence and analyze pancreatic and melanoma cancer data from Penn patients to identify patterns associated with a positive response to treatment.
The deal will join Translational Software's genetics-based clinical decision support platform with DrFirst's Rcopia medication management software.
Edico will make its Dragen platform available on new Amazon cloud instances, allowing users to scale up analysis capacity as demand for computing resources grows.
The companies will co-develop kits, which Trovagene will distribute globally, to analyze ctDNA from blood or urine using next-generation sequencing platforms.
As part of the deal, TGen will also become a subsidiary of City of Hope's parent organization, but will remain a non-profit headquartered in Arizona.
NIH has been conservative on the PMI's budget and its funds are sufficient to launch enrollment next year, begin collecting data, and initiate genetic testing pilot projects.
Evotec will use Merck's collection of genetic reagents — including viral CRISPR and shRNA libraries — in target discovery programs.
The single-cell approach enabled them to identify gene expression in rare cell types, highlighting a previously unrecognized role for these cells in diabetes.
The company plans to recruit one million patients from Mexico over three years and then expand to Columbia, Argentina, and Brazil.
Phenomenex has launched two new products for characterization and purification of synthetic oligonucleotides, the Clarity Oligo-XT C18 column and the Clarity Oligo-SAX column.
The products will be offered as part of the firm's Clarity BioSolutions portfolio of columns for chromatographic analysis.
The Oligo-XT C18 column is intended for high-efficiency reversed-phase liquid chromatography analysis and purification. Featuring new and robust core-shell media, it offers the separation power to resolve closely related synthetic oligos and the sensitivity to improve quantitation by mass spectrometry. The columns are available in directly scalable 1.7-micrometer, 2.5-micrometer, and 5-micrometer particle sizes.
The Oligo-SAX is a high-resolution strong anion exchanger for characterization, featuring new rugged non-porous particles for improved column lifetimes. It is engineered for performance at high pH and temperatures up to 85° C. It comes in a 5-micrometer particle size for analytical characterization.
The Workbench Manager helps labs manage their bioinformatics workflows while the Clinical Annotation software offers clinical variant interpretation services.